Support for Patients and Communities Reauthorization Act of 2025

June 15th, 2025

Welcome back to Policies Humanized. We break down the biggest legislative and policy stories, making them clear, personal, and actionable. We believe policy shouldn’t just be reported; it should be understood.

Support for Patients and Communities Reauthorization Act of 2025

Breaking down the “Support for Patients and Communities Reauthorization Act,” you can find the full bill here: https://www.congress.gov/bill/119th-congress/house-bill/2483

On June 4th, the bill, under number H.R.2483 was passed by the U.S. House of Representatives. Now in the Senate, the bill has been incorporated under the Bipartisan Health Care Act S.891.

Image sourced from the National Association of Counties. The image is not intended to reflect any opinions of the organization or the opinions of their authors.

What does the bill propose?

Back in 2018, the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act was signed into law. The bill was a response to the opioid epidemic, focusing on prevention, treatment, and recovery. However, at the end of September in 2023, many provisions under the original act expired.

This new bill aims to reauthorize provisions to address substance use disorders, support for mental health, overdose prevention, and bring more support to groups including pregnant and postpartum women, youths, and families.

Here is a breakdown of the bill:

Title 1: Prevention

• Allocates $4.25 million annually between fiscal years 2026 to 2030 for prenatal and postnatal health

• Expands coverage beyond opioids overdose to substances causing overdose

• Expands funding under Section 392A(e) of the Public Health Service Act to “$505,579,000 for each of fiscal years 2026 through 2030” covering prevention of overdose

• Addresses fetal Alcohol Spectrum Disorders (FASD) by expanding public awareness initiatives including educational programs, public awareness campaigns, supporting research to develop diagnostic tools, create culturally sensitive and appropriate interventions, training programs and professionals to support individuals affected by FASD, and supporting research and pilot programs to provide comprehensive services (medical care, counseling, education, job training, advocacy) tailored to individuals with FASD

• Authorizes the Department of Health and Human Services to award grants or contracts to qualified public or nonprofit organizations with expertise in Fetal Alcohol Spectrum Disorders (FASD) to strengthen national, Tribal, State, and local efforts to prevent FASD

• Congress authorizes $12.5 million per year from 2026 through 2030 to support FASD-related programs (under Sections 399H and 399I of the Public Health Service Act).

• Starting 4 years after the bill is enacted, and annually after, the Secretary of Health and Human Services must report to Congress on progress in public education and awareness efforts about FASD, details of FASD-related activities, including prevention, treatment, and outcome evaluations, and assessments of support services for individuals living with FASD

• States that states cannot be forced by the federal government to adopt a specific vendor or software system for their prescription drug monitoring programs (PDMPs)

  • The only exception is if the requirement is to comply with nationally recognized, consensus-based open standards, for example, federal health IT law which relates to interoperability and health information exchange

• Updates and expands the existing first responder training program under the Public Health Service Act to include training on heroin, opioids, and other drugs involved in overdoses, allow use of any overdose reversal product that is approved, cleared, or otherwise legally marketed, and increases funding from $36 million per year to $57 million per year from 2026 to 2030

• The Donald J. Cohen National Child Traumatic Stress Initiative (NCTSI) is a federal program that funds trauma-informed care for children affected by abuse, neglect, violence, disasters, or other traumatic events. The bill expands the scope and accountability plan under the program. Grantees would be required to not only develop evidence based trauma care practices, but also support dissemination and implementation nationwide, create training and resources for service providers, and encourages collaboration among grantees, the coordinating center, and HHS. Additionally, grantees would have to submit a clear evaluation plan with both process and outcome metrics, end-of-project assessments, and a plan to support NCTSI-led evaluations. The bill would also increase funding for 2026 to 2030.

• Protect the 988 National Suicide Prevention Lifeline from cyberattacks and data breaches through new safeguards, reporting protocols, and oversight requirements. The bill updates federal law to require the 988 Lifeline program to take necessary steps to protect against cybersecurity incidents, and eliminate known vulnerabilities in its tech systems. There are also new rules for reporting and oversight including timely notification where the national network administrator and local/regional crisis centers must report any vulnerabilities or cybersecurity incidents to the Assistant Secretary at HHS while protecting user privacy under federal and state laws. Local crisis centers may be subjected to tech oversight if its in their contract and within 180 days of the bill becoming law, the U.S. Comptroller General must conduct a full study on cybersecurity risks facing the 988 Lifeline and submit a report to relevant Congressional committees.

• Increases federal funding for programs that monitor and report on trauma experienced by children, youth, and adults from $2 million a year to $9 million a year from 2026 through 2030

• Bruce's Law contains national efforts to prevent youth drug misuse and respond to the growing crisis of fentanyl contaminated drugs. The bill would expand existing federal substance use laws to expand education and awareness about synthetic opioids, especially fentanyl. A new federal interagency work group that focuses on fentanyl contamination would be formed under the U.S. Department of Health and Human Services (US HHS) to coordinate national efforts in reducing overdoses caused by fentanyl contaminated drugs, support families affected by overdoses, improve state and local responses, recommend public education strategies, and submit annual reports to congress and the US HHS with findings and policy suggestions. Additionally, the federal substance use disorder coordinating committee will be extended until the end of September in 2030.

• Requires the U.S. Department of Health and Human Services (HHS) in partnership with the Drug Enforcement Administration (DEA) to create clear national guidance on how to safely dispose of unused or expired medications from home without needing to go to a collection site

• Within one year, the U.S. Department of Health and Human Services (HHS) must publish a public report on the FDA’s website outlining how the FDA is evaluating the risks and benefits of opioid pain medications and what it's doing to support non-addictive alternatives and the FDA must allow the public to provide input on how opioids are regulated including any scientific evidence about how these drugs are used, their safety, and their overall public health impact

• Clarifies that federal grants to States and Tribes can be used to buy and distribute tools that help prevent overdose deaths, including fentanyl test strips, xylazine test strips, and other drug-checking products if it is legal under both federal and state law

Title II: Treatment

• Allow programs to create outreach plans for women disproportionately affected by maternal substance use disorders and increases funding to $38,931,000 each year for 2026 to 2030

• Expands federal support to train more addiction medicine professionals

• Extends federal education and training grants for mental/behavioral health professionals through 2030

• Raises funding for loan repayment programs for those working in substance use treatment from $25M to $40M annually between 2026 to 2030

• Removes the outdated requirement for training on patient record privacy laws and streamlining education materials

• Expands membership for the Trauma Informed Care Task Force by adding developmental disability service providers and the Administration for Community Living and extending the task force through 2030

• Simplifies language in the grant section for grants for Substance Use Disorder Treatment Access

• Requires HHS to review how states use block grants for early psychosis and youth mental health and requires a report to be submitted to Congress with updated guidance to follow

• Directs the HHS and the Department Of Justice to consider whether combo drugs like Suboxone, Buprenorphine/ Naloxone should be rescheduled , potentially lowering restrictions

• Ensures grant language refers to all approved reversal drugs, not just naloxone, for opioid overdose treatment

• Requires a national roundtable on expanding use of electronic health records (EHRs) in mental health and addiction treatment that will result in a detailed report to Congress on adoption, cost, best practices, and integration (for example, with 988 crisis lines)

Title III: Recovery

• Boosts funding from $5M to $17M per year from 2026 to 2030 to support peer-led recovery networks and community-based addiction recovery programs

• Expands training and resources for peer support specialists and allowing the HHS to set up regional centers to tailor recovery support efforts, as well as increasing funding for peer assistance technical center from $1M to $2M per year between 2026 to 2030

• Extends Comprehensive Opioid Recovery Centers programs through 2030 while requiring more robust reporting from grantees, especially those using referral networks

• For Youth Prevention and Recovery, funding eligibility will expand to secondary schools and programs will emphasize peer-to-peer support, outreach to high-risk youth, and sustainability. Funding for these programs will scale up to expand each year between 2026 to 2030.

• Under the CAREER Act, the bill reauthorizes and expands grants for job training and employment support for people recovering from substance use. Grantees will be able to use up to 5% of funds for transportation to work or treatment. The bill puts priority on areas with high overdose and unemployment rates according to 2018–2022 data, increases funding and reauthorizes the Recovery Housing Pilot Program.

• Extends programs that help communities cope with the economic fallout of the opioid crisis through 2030

• Makes it mandatory for the HHS to hold a public meeting within 1 year to improve access to Substance Abuse and Mental Health Services Administration (SAMHSA) funding. The bill aims to make Grants.gov more usable, building dashboards, and helping first-time applicants. HHS will be required to submit a report on changes implemented, especially as it relates to equity and access.

Title IV: Miscellaneous

• Pharmacies will be allowed to deliver certain Schedule III, IV, or V drugs directly to prescribing practitioners but only if:

  1. The drug is used for injection or implantation as part of detox or maintenance treatment for substance use disorders OR

  2. The drug is subject to strict FDA safety rules (called REMS with Elements to Assure Safe Use) that require the patient to be monitored by a healthcare provider after administration

• Expands the list of organizations and educational programs whose training programs count toward the mandatory controlled substances training for healthcare providers to include

  • Podiatrists, optometrists, pharmacists, psychiatric nurses, and family physicians through their respective national associations

  • Accredited schools of podiatric medicine and pharmacy as valid sources of required training

  
  

What are the impacts?

The Support for Patients and Communities Reauthorization Act is a major national efforts in addressing both the opioid crisis and expanding coverage to acknowledge broader substance use, mental health challenges, and overdose. The biggest strength of the bill is how comprehensive it is. The bill extends funding through 2030 for prevention, treatment, and recovery, while also expanding support for vulnerable groups like youth, pregnant women, and people in recovery. This ensures that states will not lose funding for these critical programs and that constituents who benefit from these programs continue receiving its benefits. It invests in more addiction treatment providers, mental health workforce training, and tools like fentanyl test strips and electronic health records to improve care.

One key impact is helping communities build stronger, peer-led recovery networks and job support systems, recognizing addiction as both a health and economic issue. However, a weakness is that much of the law depends on successful coordination across federal and state agencies, especially the HHS, which has struggled in the past with delays and uneven implementation and more recently the subject to massive scrutiny. There are also uncertainties around whether new public education campaigns and pilot programs will reach the people who need them most, and how effectively the Department of Health and Human Services will carry out tasks like issuing guidance, reports, and updating tech systems. The bill is still important, signaling a continued national commitment to fighting addiction with better care, more tools, and a focus on long-term support rather than just short-term fixes, however the process and consequences of these proposals should be watched closely and continuously evaluated itself.

Additionally, while bill promises expanded programs, increase funding, and create stronger overdose prevention tools, its actual impact may be limited by recent cuts to public health funding. Over the past year, major public health institutions including the Center for Disease Control (CDC) and the National Institute of Health (NIH) have seen reductions or cancelations of research grants and huge workforce layoffs. Meanwhile, other bills in Congress are competing for limited health dollars. All of this raises questions about whether the funding authorized in this bill will be fully delivered if it passes the senate and is signed into law as well as whether agencies will have the staffing and infrastructure needed to carry it out effectively. Despite the vision for public health improvements, the monetary resources crucial to implementation efforts is lacking.

What can you do?

• Stay Informed, follow updates on the bill and related legislation

• Contact your senators, you can call or email their office to let them know this bill matters, tell your personal stories, and follow up

• Join or support organizations including any community health groups, harm reduction coalitions, and mental health networks that are already doing this work. You can support them by volunteering, donating, or attending public meetings. Ask them how you can help advance their interest for the bill!

• Raise Awareness and share accurate, accessible information on social media or in your community. Have conversations and fight against the stigmas of substance use and mental health. When more people understand the bill’s stakes, the more support the bill will have and the more likely your elected officials hear you.

• Ask questions! If your lawmakers or other agencies host public forums, ask how they plan to implement programs and expand initiatives mentioned in the bill and what they will do if funding falls short. Watch the national, state, and local budget and pay attention to where health dollars are actually going.